Polymorphism of Biotransformation Genes and Risk of Relapse in Childhood Acute Leukemia

Wood ME, Philips GK. Hematology/Oncology Secrets. 3rd ed. Philadelphia: Hanley & Belfus Inc., 2003.Search in Google Scholar

Chan KW. Acute lymphoblastic leukemia. Curr Probl Pediatr Adolesc Health Care 2002; 32(2): 40-49.10.1067/mps.2002.12179011951089Search in Google Scholar

Ansari M, Krajinovic M. Pharmacogenomics of acute leukemia. Pharmacogenomics 2007; 8(7): 817-834.10.2217/14622416.8.7.81718240908Search in Google Scholar

Seeger K, Adams HP, Buchwald D, Beyermann B, Kremens B, Niemeyer C, Ritter J, Schwabe D, Harms D, Schrappe M, Henze G. TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Munster Study Group. Blood 1998; 91(5): 1716-1722.10.1182/blood.V91.5.1716.1716_1716_1722Search in Google Scholar

Relling MV, Yanishevski Y, Nemec J, Evans WE, Boyett JM, Behm FG, Pui CH. Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia. Leukemia 1998; 12(3): 346-352.10.1038/sj.leu.24009289529129Search in Google Scholar

Chupova NV, Samochatova EV, Rudneva AE, Solopova GG, Nasedkina TV, Fedorova OE, Glotov AS, Zemliakova VV, Krynetski EYu, Krynetskaia NF, Ribeiro RC, Evans WE, Rumyantsev AG. Genetic polymorphism of thiopurine-S-methyltransferase and treatment of childhood acute lymphoblastic leukemia. Haematol Transfusiol (in Russian with English abstract) 2005; 6: 3-8.Search in Google Scholar

Gra OA, Glotov AS, Nikitin EA, Glotov OS, Kuznetsova VE, Chudinov AV, Sudarikov AB, Nasedkina TV. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients. Am J Hematol 2008; 83(4): 279-287.10.1002/ajh.2111318061941Search in Google Scholar

Gra OA, Glotov AS, Kozhekbaeva ZhM, Makarova OV, Nasedkina TV. Genetic polymorphism of GST, NAT2, and MTRR and susceptibility to childhood acute leukemia. Mol Biol (Mosk) 2008; 42(2): 187-197.10.1134/S0026893308020039Search in Google Scholar

Sohn KJ, Croxford R, Yates Z, Lucock M, Kim YI. Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate. J Natl Cancer Inst 2004; 96(2): 134-144.10.1093/jnci/djh01514734703Search in Google Scholar

Stanulla M, Schaeffeler E, Flohr T, Cario G, Schrauder A, Zimmermann M, Welte K, Ludwig WD, Bartram CR, Zanger UM, Eichelbaum M, Schrappe M, Schwab M. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. JAMA 2005; 293(12): 1485-1489.10.1001/jama.293.12.148515784872Search in Google Scholar

Krajinovic M, Richer C, Sinnett H, Labuda D, Sinnett D. Genetic polymorphisms of N-acetyltransferases 1 and 2 and gene-gene interaction in the susceptibility to childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 2000; 9(6): 557-562.Search in Google Scholar

Krajinovic M, Labuda D, Richer C, Karimi S, Sinnett D. Susceptibility to childhood acute lymphoblastic leukemia: influence of CYP1A1, CYP2D6, GSTM1, and GSTT1 genetic polymorphisms. Blood 1999; 93(5): 1496-1501.10.1182/blood.V93.5.1496Search in Google Scholar

Smith MT, Wang Y, Skibola CF, Slater DJ, Lo Nigro L, Nowell PC, Lange BJ, Felix CA. Low NAD(P)H: quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children. Blood 2002; 100(13): 4590-4593.10.1182/blood-2001-12-026412393620Search in Google Scholar

Infante-Rivard C, Labuda D, Krajinovic M, Sinnett D. Risk of childhood leukemia associated with exposure to pesticides and with gene polymorphisms. Epidemiology 1999; 10(5): 481-487.10.1097/00001648-199909000-00004Search in Google Scholar

Takanashi M, Morimoto A, Yagi T, Kuriyama K, Kano G, Imamura T, Hibi S, Todo S, Imashuku S. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia. Haematologica 2003; 88(11): 1238-1244.Search in Google Scholar

Krajinovic M, Labuda D, Mathonnet G, Labuda M, Moghrabi A, Champagne J, Sinnett D. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia. Clin Cancer Res 2002; 8(3): 802-810.Search in Google Scholar

Rocha JC, Cheng C, Liu W, Kishi S, Das S, Cook EH, Sandlund JT, Rubnitz J, Ribeiro R, Campana D, Pui CH, Evans WE, Relling MV. Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood 2005; 105(12): 4752-4758.10.1182/blood-2004-11-4544189500615713801Search in Google Scholar

Stanulla M, Schrappe M, Brechlin AM, Zimmermann M, Welte K. Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study. Blood 2000; 95(4): 1222-1228.10.1182/blood.V95.4.1222.004k20_1222_1228Search in Google Scholar

Voso MT, D'Alo F, Gumiero D, Guidi F, Hohaus S, Leone G. The CYP1A1*2a allele is an independent prognostic factor for acute myeloid leukemia. Haematologica 2005; 90(7): 982-984.Search in Google Scholar

Anderer G, Schrappe M, Brechlin AM, Lauten M, Muti P, Welte K, Stanulla M. Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukemia. Pharmacogenetics 2000; 10(8): 715-726.10.1097/00008571-200011000-0000611186134Search in Google Scholar

Glotov AS, Nasedkina TV, Ivashchenko TE, Iurasov RA, Surzhikov SA, Pan'kov SV, Chudinov AV, Baranov VS, Zasedatelev AS. Biochip development for polymorphism analysis in biotransformation system genes. Mol Biol (Mosk) 2005; 39(3): 403-412.10.1007/s11008-005-0050-8Search in Google Scholar

Nasedkina TV, Fedorova OE, Glotov AS, Chupova NV, Samochatova EV, Maiorova OA, Zemlyakova VV, Roudneva AE, Chudinov AV, Yurasov RA, Kozhekbaeva JM, Barsky VE, Krynetskiy EY, Krynetskaia NF, Cheng C, Ribeiro RC, Evans WE, Roumyantsev AG, Zasedatelev AS. Rapid genotyping of common deficient thiopurine Smethyltransferase alleles using the DNA-microchip technique. Eur J Hum Genet 2006; 14(9): 991-998.10.1038/sj.ejhg.520164716724002Search in Google Scholar

Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Warrenton, VA, USA, November 1997. Hematol J 2000; 1(1): 53-66.10.1038/sj.thj.620001311920170Search in Google Scholar

Surzhikov SA, Timofeev EN, Chernov BK, Golova JB, Mirzabekov AD. Advanced method for oligonucleotide deprotection. Nucleic Acids Res 2000; 28(8):E29.10.1093/nar/28.8.e2910283310734206Search in Google Scholar

Rubina AY, Pan'kov SV, Dementieva EI, Pen'kov DN, Butygin AV, Vasiliskov VA, Chudinov AV, Mikheikin AL, Mikhailovich VM, Mirzabekov AD. Hydrogel drop microchips with immobilized DNA: properties and methods for large-scale production. Anal Biochem 2004; 325(1): 92-106.10.1016/j.ab.2003.10.01014715289Search in Google Scholar

Celander M, Weisbrod R, Stegeman JJ. Glucocorticoid potentiation of cytochrome P4501A1 induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in porcine and human endothelial cells in culture. Biochem Biophys Res Commun 1997; 232(3): 749-753.10.1006/bbrc.1997.63669126348Search in Google Scholar

Tew KD. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 1994; 54(16): 4313-4320.Search in Google Scholar

Yuan ZM, Smith PB, Brundrett RB, Colvin M, Fenselau C. Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry. Drug Metab Dispos 1991; 19(3): 625-629.Search in Google Scholar

Vester U, Kranz B, Zimmermann S, Buscher R, Hoyer PF. The response to cyclophosphamide in steroid-sensitive nephrotic syndrome is influenced by polymorphic expression of glutathion-S-transferases- M1 and -P1. Pediatr Nephrol 2005; 20(4): 478-481.10.1007/s00467-004-1759-7Search in Google Scholar

Zhang J, Tian Q, Yung Chan S, Chuen Li S, Zhou S, Duan W, Zhu YZ. Metabolism and transport of oxazaphosphorines and the clinical implications. Drug Metab Rev 2005; 37(4): 611-703.10.1080/03602530500364023Search in Google Scholar

Papageorgiou G, Iliadis S, Botsoglou N, Dioudis C, Goulas A, Fletouris D, Dimitriadou-Vafiadou A. Lipid peroxidation of rat myocardial tissue following daunomycin administration. Toxicology 1998; 126(2): 83-91.10.1016/S0300-483X(98)00002-XSearch in Google Scholar

Autrup JL, Hokland P, Pedersen L, Autrup H. Effect of glutathione S-transferases on the survival of patients with acute myeloid leukaemia. Eur J Pharmacol 2002; 438(1-2): 15-18.10.1016/S0014-2999(02)01290-6Search in Google Scholar

Pompeo F, Brooke E, Kawamura A, Mushtaq A, Sim E. The pharmacogenetics of NAT: structural aspects. Pharmacogenomics 2002; 3(1): 19-30.10.1517/14622416.3.1.1911966400Search in Google Scholar

Goldenkova-Pavlova IV, Bruskin SA, Abdeev RM, Markarova EV, Bigvava SG, Radkevich LA, Kozhekbaeva ZhM, Glotov AS, Gra OA, Zasedatelev AS, Nasedkina TV, Kurdanov KhA, Piruzian ES. Comparative analysis of N-acetylation polymorphism in humans as determined by phenotyping and genotyping. Genetika 2006; 42(8): 1143-1150.Search in Google Scholar

Kozhekbaeva ZhM, Glotov AS, Gra OA, Golden-kova-Pavlova IV, Bruskin SA, Agafonova EE, Markarova EV, Abdeev RM, Korsunskaia IM, Piruzian AL, Barskii VE, Zasedatelev AS, Nasedkin TV. Identification of functionally significant mutations in NAT2 gene using biological microchips. Mol Biol (Mosk) 2007; 41(4): 725-733.Search in Google Scholar

Leff MA, Fretland AJ, Doll MA, Hein DW. Novel human N-acetyltransferase 2 alleles that differ in mechanism for slow acetylator phenotype. J Biol Chem 1999; 274(49): 34519-34522.10.1074/jbc.274.49.3451910574910Search in Google Scholar

Hein DW. N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk. Oncogene 2006; 25(11): 1649-1658.10.1038/sj.onc.1209374143472116550165Search in Google Scholar

Borlak J, Reamon-Buettner SM. N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients. BMC Med Genet 2006; 7: 58.10.1186/1471-2350-7-58153381216827944Search in Google Scholar

Chiou HL, Wu MF, Chien WP, Cheng YW, Wong RH, Chen CY, Lin TS, Lee H. NAT2 fast acetylator genotype is associated with an increased risk of lung cancer among never-smoking women in Taiwan. Cancer Lett 2005; 223(1): 93-101.10.1016/j.canlet.2004.12.01515890241Search in Google Scholar

Meyer UA, Zanger UM. Molecular mechanisms of genetic polymorphisms of drug metabolism. Annu Rev Pharmacol Toxicol 1997; 37: 269-296.10.1146/annurev.pharmtox.37.1.2699131254Search in Google Scholar

Acar H, Caliskan U, Demirel S, Largaespada DA. Micronucleus incidence and their chromosomal origin related to therapy in acute lymphoblastic leukemia (ALL) patients: detection by micronucleus and FISH techniques. Teratog Carcinog Mutagen 2001; 21(5): 341-347.10.1002/tcm.102211746248Search in Google Scholar

Emoto Y, Kisaki H, Manome Y, Kharbanda S, Kufe D. Activation of protein kinase Cδ in human myeloid leukemia cells treated with 1-β-Darabinofuranosylcytosine. Blood 1996; 87(5): 1990-1996.10.1182/blood.V87.5.1990.1990Search in Google Scholar

Chessells JM, Richards SM, Bailey CC, Lilleyman JS, Eden OB. Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials. Br J Haematol 1995; 89(2): 364-372.10.1111/j.1365-2141.1995.tb03313.x7873387Search in Google Scholar

Schroeder H, Garwicz S, Kristinsson J, Siimes MA, Wesenberg F, Gustafsson G. Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology (NOPHO). Med Pediatr Oncol 1995; 25(5): 372-378.10.1002/mpo.29502505037674994Search in Google Scholar

Moorman AV, Richards SM, Martineau M, Cheung KL, Robinson HM, Jalali GR, Broadfield ZJ, Harris RL, Taylor KE, Gibson BE, Hann IM, Hill FG, Kinsey SE, Eden TO, Mitchell CD, Harrison CJ. Outcome heterogeneity in childhood highhyperdiploid acute lymphoblastic leukemia. Blood 2003; 102(8): 2756-2762.10.1182/blood-2003-04-112812829593Search in Google Scholar